Search the Video Library

Filter by Date

Video Language

Filter by Cancer Type:

Displaying Results 106 - 108 of 108

SBRT for Oligometastatic Lung Cancer

Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines oligometastatic lung cancer and describes the recent trend toward the use of stereotactic body radiation therapy to treat it.

Immunotherapy for First Line Therapy of Advanced NSCLC

Dr. Eddie Garon considers the data on immunotherapies for first line treatment of advanced NSCLC and whether we are likely to use these agents instead of or in combination with standard chemotherapy soon.

What is the Optimal Duration of Immunotherapy?

UCLA Med Center's Dr. Eddie Garon discusses the open question of the optimal duration of ongoing treatment with immunotherapy for lung cancer.